OBJECTIVE: To determine if the improved risk factor profile at 1 year attributed to the Choice of Health Options In prevention of Cardiovascular Events (CHOICE) program was maintained at 4 years. DESIGN: Single-blind randomized controlled trial with post-hoc 476 months follow-up (76% complete). SETTING:Australian tertiary referral hospital. PATIENTS: Two hundred and eight acute coronary syndrome survivors. INTERVENTIONS:Acute coronary syndrome survivors not accessing cardiac rehabilitation (CR) were randomized to control (n=72) or CHOICE (n=72) comprising the tailored risk factor reduction packaged as a clinic visit and 3 months phone support. A contemporary CR reference group were also recruited (n=64). Blinded risk assessment occurred at baseline, 1 and 4 years. MAIN OUTCOME MEASURES: Total cholesterol, systolic blood pressure, smoking status, physical activity. RESULTS: One year improvements in all the modifiable risk factors achieved in CHOICE were maintained at 4 years. CHOICE and control were well-matched at baseline. At 4 years, there was a trend towards lower total cholesterol in CHOICE compared with controls (mean 4.0±0.1 vs. 4.2±0.1 mmol/l, P=0.05), significantly better systolic blood pressure (mean 132.2±2.1 vs. 136.8±2.0 mmHg, P=0.01), physical activity scores (1200±209 vs. 968±196 metabolic equivalent min/week, P=0.02) and proportion with three or more risk factors above national targets (20 vs. 42%,P=0.02). Participants in CHOICE were at higher baseline risk than CR but at 4 years they had similar risk factor profiles. CONCLUSION: Participants in CHOICE maintained favorable changes in coronary risk profile at 4 years compared with control, indicating that CHOICE is an effective long-term intervention among those not accessing facility-based CR.
RCT Entities:
OBJECTIVE: To determine if the improved risk factor profile at 1 year attributed to the Choice of Health Options In prevention of Cardiovascular Events (CHOICE) program was maintained at 4 years. DESIGN: Single-blind randomized controlled trial with post-hoc 476 months follow-up (76% complete). SETTING: Australian tertiary referral hospital. PATIENTS: Two hundred and eight acute coronary syndrome survivors. INTERVENTIONS: Acute coronary syndrome survivors not accessing cardiac rehabilitation (CR) were randomized to control (n=72) or CHOICE (n=72) comprising the tailored risk factor reduction packaged as a clinic visit and 3 months phone support. A contemporary CR reference group were also recruited (n=64). Blinded risk assessment occurred at baseline, 1 and 4 years. MAIN OUTCOME MEASURES: Total cholesterol, systolic blood pressure, smoking status, physical activity. RESULTS: One year improvements in all the modifiable risk factors achieved in CHOICE were maintained at 4 years. CHOICE and control were well-matched at baseline. At 4 years, there was a trend towards lower total cholesterol in CHOICE compared with controls (mean 4.0±0.1 vs. 4.2±0.1 mmol/l, P=0.05), significantly better systolic blood pressure (mean 132.2±2.1 vs. 136.8±2.0 mmHg, P=0.01), physical activity scores (1200±209 vs. 968±196 metabolic equivalent min/week, P=0.02) and proportion with three or more risk factors above national targets (20 vs. 42%,P=0.02). Participants in CHOICE were at higher baseline risk than CR but at 4 years they had similar risk factor profiles. CONCLUSION:Participants in CHOICE maintained favorable changes in coronary risk profile at 4 years compared with control, indicating that CHOICE is an effective long-term intervention among those not accessing facility-based CR.
Authors: Anjana E Sharma; Rachel Willard-Grace; Danielle Hessler; Thomas Bodenheimer; David H Thom Journal: Ann Fam Med Date: 2016-05 Impact factor: 5.166
Authors: Anna-Lotta Irewall; Lisa Bergström; Joachim Ogren; Katarina Laurell; Lars Söderström; Thomas Mooe Journal: Cerebrovasc Dis Extra Date: 2014-02-19
Authors: Thomas Mooe; Fredrik Björklund; Anna Graipe; Daniel Huber; Stina Jakobsson; Ulf Kajermo; Anna Strömvall; Anders Ulvenstam Journal: JMIR Res Protoc Date: 2014-08-15
Authors: Anna Barker; Peter Cameron; Leon Flicker; Glenn Arendts; Caroline Brand; Christopher Etherton-Beer; Andrew Forbes; Terry Haines; Anne-Marie Hill; Peter Hunter; Judy Lowthian; Samuel R Nyman; Julie Redfern; De Villiers Smit; Nicholas Waldron; Eileen Boyle; Ellen MacDonald; Darshini Ayton; Renata Morello; Keith Hill Journal: PLoS Med Date: 2019-05-24 Impact factor: 11.069
Authors: Nader N Kabboul; George Tomlinson; Troy A Francis; Sherry L Grace; Gabriela Chaves; Valeria Rac; Tamara Daou-Kabboul; Joanna M Bielecki; David A Alter; Murray Krahn Journal: J Clin Med Date: 2018-12-04 Impact factor: 4.241